Drugnet Europe 87
In this issue: EMCDDA scientific paper award 2014, etc.
Joint Report on MT-45
In April 2014, the EMCDDA and Europol examined the available information on a new psychoactive substance 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine, commonly known as MT-45.
Annual accounts 2013
The financial statements of the EMCDDA and the reports on implementation of the budget.
Joint Report on 4,4′-DMAR
In February 2014, the EMCDDA and Europol examined the available information on a new psychoactive substance, 4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (commonly known by the abbreviation 4,4′-DMAR).
Residential treatment for drug use in Europe
The aim of this paper is to provide a Europe-wide overview of the history and availability of residential drug treatment within wider national drug treatment systems.